文献速递新生儿儿童消化与营养

新生儿急性肝衰竭特异性预后标志物:入院甲胎蛋白与新型评分预测结局

Establishing Neonate-Specific Prognostic Markers in Acute Liver Failure: Admission Alpha Fetoprotein and Novel Neonatal Acute Liver Failure Scores Predict Patient Outcomes.
PubMed 文献 · J Pediatr · 2024-04-29

该单中心回顾性研究纳入2005至2022年51例≤30天新生儿急性肝衰竭患儿,旨在建立预测自体肝生存(SNL)的新生儿特异性模型。总体SNL率为43%,非妊娠同种免疫性肝病患儿中甲胎蛋白<4775 ng/mL预测死亡或移植的灵敏度75%、特异度100%,曲线下面积0.81;基于国际标准化比值和氨的入院模型及基于凝血酶原时间和氨的峰值模型曲线下面积分别为0.73和0.82。

要点

  • 新生儿急性肝衰竭总体自体肝生存率为43%。
  • 非妊娠同种免疫性肝病患儿中,甲胎蛋白<4775 ng/mL预测死亡或移植的曲线下面积为0.81。
  • 新生儿特异性入院模型(国际标准化比值和氨)与峰值模型(凝血酶原时间和氨)预测自体肝生存曲线下面积分别为0.73和0.82。

核心结论

  • 研究识别了新生儿急性肝衰竭自体肝生存的新生儿特异性预后变量,可能有助于早期风险分层以指导医疗决策和肝移植评估。

研究设计与样本

  • 单中心回顾性病历审查,纳入2005年至2022年≤30天新生儿急性肝衰竭患儿,定义条件为国际标准化比值≥2或凝血酶原时间≥20秒且存在肝功能障碍,共51例符合标准。

主要发现

  • 新生儿急性肝衰竭最常见病因包括缺血(22%)、感染(20%)和妊娠同种免疫性肝病(16%)。
  • 总体自体肝生存率为43%(n=22)。
  • 非妊娠同种免疫性肝病患者中,甲胎蛋白<4775 ng/mL预测死亡或移植的灵敏度75%、特异度100%,曲线下面积0.81。

关键数值与推荐

  • 新生儿急性肝衰竭定义:国际标准化比值≥2或凝血酶原时间≥20秒且存在肝功能障碍。
  • 甲胎蛋白<4775 ng/mL预测非妊娠同种免疫性肝病患者死亡或移植的灵敏度75%、特异度100%,曲线下面积0.81。
  • 新生儿特异性入院模型(国际标准化比值和氨)预测自体肝生存曲线下面积0.73。
  • 新生儿特异性峰值模型(凝血酶原时间和氨)预测自体肝生存曲线下面积0.82。

临床怎么用

  • 入院时检测甲胎蛋白、国际标准化比值和氨,住院期间监测凝血酶原时间和氨峰值,可辅助新生儿急性肝衰竭的早期风险分层。
  • 对非妊娠同种免疫性肝病新生儿,甲胎蛋白<4775 ng/mL提示死亡或移植风险高,可考虑加强监测和提前评估肝移植。

局限性

  • 研究为单中心回顾性设计,样本量51例,结论需外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To develop neonate-specific prediction models for survival with native liver (SNL) in neonatal acute liver failure (ALF) and to determine if these prediction models have superior accuracy to existing models for older children with ALF. STUDY DESIGN: A single-center, retrospective chart review was conducted on neonates ≤ 30 days of life between 2005 and 2022 with ALF (international normalized ratio ≥ 2 or prothrombin time ≥ 20s and liver dysfunction). Statistical analysis included comparison of patients by outcome of SNL and generalized linear modeling to derive prediction models. The predictive accuracy of variables was evaluated by receiver operating characteristic (ROC) analysis and Kaplan-Meier survival analysis. RESULTS: A total of 51 patients met inclusion criteria. The most common causes of neonatal ALF included ischemia (22%), infection (20%), and gestational alloimmune liver disease (16%). Overall SNL rate was 43% (n = 22). Alpha fetoprotein levels were higher in SNL patients (P = .034) and differed more significantly by SNL status among nongestational alloimmune liver disease patients (n = 21, P = .001). An alpha fetoprotein < 4775 ng/mL had 75% sensitivity and 100% specificity to predict death or transplant in nongestational alloimmune liver disease patients with an area under the ROC curve of 0.81. A neonate-specific admission model (international normalized ratio and ammonia) and peak model (prothrombin time and ammonia) also predicted SNL with good accuracy (area under the ROC curve = 0.73 and 0.82, respectively). CONCLUSIONS: We identified neonate-specific prognostic variables for SNL in ALF. Findings from our study may help early risk stratification to guide medical decision-making and consideration for liver transplantation.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Rolfes PS, Sundaram SS, Sokol RJ, et al. Establishing Neonate-Specific Prognostic Markers in Acute Liver Failure: Admission Alpha Fetoprotein and Novel Neonatal Acute Liver Failure Scores Predict Patient Outcomes. J Pediatr. 2024. PMID: 38692563. doi:10.1016/j.jpeds.2024.114080

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。